2024 Senate Bill 1179

Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit.

A bill to amend 1978 PA 368, entitled “Public health code,” (MCL 333.1101 to 333.25211) by adding section 17757c.

AI Analysis – Experimental

The bill amends the Public Health Code to prevent manufacturers and distributors from limiting access to 340B drugs for eligible entities and their authorized pharmacies, with exceptions allowed under state or federal law.

Introduced in the Senate

Dec. 4, 2024

Introduced by Sen. Sam Singh (D-28)

Referred to the Committee on Oversight

Dec. 11, 2024

Reported without amendment

Dec. 12, 2024

Referred to the Committee of the Whole

Dec. 13, 2024

Reported with substitute S-5

Substitute S-5 concurred in by voice vote

Amendment offered by Sen. Ed McBroom (R-38)

1. Amend page 2, following line 1, by inserting:

“(c) If a 340B entity has more than 1 facility, prohibit the 340B entity from entering into a contract with not more than 2 pharmacies in each county where the 340B entity is physically present to receive a 340B drug on behalf of the 340B entity. A pharmacy that is located on the premises of the 340B entity is not considered a pharmacy for purposes of this subdivision.” and by relettering the remaining subdivision.

2. Amend page 2, line 4, after “subdivision” by striking out “(a) or (b)” and inserting “(a), (b), or (c)”.

The amendment failed by voice vote

Passed in the Senate 30 to 3 (details)

Received in the House

Dec. 13, 2024

Referred to the Committee on Government Operations